Communicating with government officials, in general, about policies and programs related to improving access for British Columbia patients to effective treatments for common mental health, addiction and neuro-degenerative conditions.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Mental Health and Addictions, Science and Technology
|
Communicating with government officials, in general, about support for innovative research and development in the biopharmaceutical sector.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Science and Technology
|
Communicating with government officials about obtaining market access for Lundbeck’s products, including listing Lundbeck’s products on the BC PharmaCare Formulary.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health, Science and Technology
|